Merck Gross Profit 2012-2026 | MKKGY

Merck annual/quarterly gross profit history and growth rate from 2012 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Merck gross profit for the quarter ending June 30, 2026 was $3.681B, a 7.13% increase year-over-year.
  • Merck gross profit for the twelve months ending June 30, 2026 was $14.487B, a 7.22% increase year-over-year.
  • Merck annual gross profit for 2025 was $13.968B, a 3.39% increase from 2024.
  • Merck annual gross profit for 2024 was $13.51B, a 0.72% increase from 2023.
  • Merck annual gross profit for 2023 was $13.413B, a 7.11% decline from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Merck Annual Gross Profit
(Millions of US $)
2025 $13,968
2024 $13,510
2023 $13,413
2022 $14,440
2021 $14,595
2020 $12,221
2019 $11,364
2018 $11,165
2017 $11,311
2016 $10,870
2015 $9,730
2014 $10,600
2013 $10,763
2012 $10,308
2011 $9,915
Merck Quarterly Gross Profit
(Millions of US $)
2026-06-30 $3,681
2026-03-31 $3,587
2025-12-31 $3,463
2025-09-30 $3,756
2025-06-30 $3,436
2025-03-31 $3,313
2024-12-31 $3,304
2024-09-30 $3,457
2024-06-30 $3,482
2024-03-31 $3,267
2023-12-31 $3,123
2023-09-30 $3,277
2023-06-30 $3,449
2023-03-31 $3,564
2022-12-31 $3,470
2022-09-30 $3,685
2022-06-30 $3,681
2022-03-31 $3,603
2021-12-31 $3,731
2021-09-30 $3,672
2021-06-30 $3,683
2021-03-31 $3,508
2020-12-31 $3,340
2020-09-30 $3,122
2020-06-30 $2,763
2020-03-31 $2,996
2019-12-31 $2,987
2019-09-30 $2,865
2019-06-30 $2,829
2019-03-31 $2,683
2018-12-31 $2,601
2018-09-30 $2,796
2018-06-30 $2,854
2018-03-31 $2,914
2017-12-31 $2,908
2017-09-30 $2,854
2017-06-30 $2,816
2017-03-31 $2,734
2016-12-31 $2,696
2016-09-30 $2,760
2016-06-30 $2,813
2016-03-31 $2,601
2015-12-31 $2,537
2015-09-30 $2,444
2015-06-30 $2,437
2015-03-31 $2,366
2014-12-31 $2,114
2014-09-30 $2,638
2014-06-30 $2,690
2014-03-31 $2,644
2013-12-31 $2,672
2013-09-30 $2,687
2013-06-30 $2,767
2013-03-31 $2,625
2012-12-31 $3,646
2012-09-30 $2,570
2012-06-30 $2,482
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.487B $23.869B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.396B 22.59
Takeda Pharmaceutical (TAK) Japan $59.919B 11.13
UCB SA (UCBJY) Belgium $45.739B 0.00
Otsuka Holdings, - (OTSKY) Japan $39.680B 14.84
BeOne Medicines - (ONC) Switzerland $38.041B 61.00
Sandoz Group AG (SDZNY) Switzerland $35.464B 0.00
Daiichi Sankyo, - (DSNKY) Japan $34.072B 21.27
Zoetis (ZTS) United States $30.343B 11.16
Astellas Pharma (ALPMY) Japan $26.892B 8.90
United Therapeutics (UTHR) United States $21.460B 17.90
Shionogi (SGIOY) Japan $15.947B 9.37
IPSEN (IPSEY) France $15.395B 0.00
Neurocrine Biosciences (NBIX) United States $15.249B 20.72
Summit Therapeutics (SMMT) United States $13.881B 0.00
Orion OYJ (ORINY) Finland $12.984B 18.93
Madrigal Pharmaceuticals (MDGL) United States $12.089B 0.00
Corcept Therapeutics (CORT) United States $11.979B 263.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Eisai (ESAIY) $8.924B 0.00
Ionis Pharmaceuticals (IONS) United States $7.852B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.523B 32.64
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
Oruka Therapeutics (ORKA) United States $6.105B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.317B 19.36
Grifols, S.A (GRFS) Spain $5.009B 0.00
Definium Therapeutics (DFTX) United States $4.947B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.157B 0.00
Indivior Pharmaceuticals (INDV) United States $4.039B 9.38
Enliven Therapeutics (ELVN) United States $3.910B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Amylyx Pharmaceuticals (AMLX) United States $3.694B 0.00
Dyne Therapeutics (DYN) United States $3.343B 0.00
Hypermarcas (HYPMY) Brazil $3.203B 9.10
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.529B 0.00
Guardian Pharmacy Services (GRDN) United States $2.390B 45.28
Nektar Therapeutics (NKTR) United States $2.275B 0.00
Ocular Therapeutix (OCUL) United States $2.238B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.146B 15.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.085B 5.63
Xencor (XNCR) United States $1.766B 0.00
KARDIGAN INC (KARD) United States $1.735B 0.00
Xeris Biopharma Holdings (XERS) United States $1.366B 107.00
Harrow (HROW) United States $1.269B 0.00
Seaport Therapeutics (SPTX) United States $1.229B 0.00
Aktis Oncology (AKTS) United States $1.204B 0.00
Cronos Group (CRON) Canada $1.179B 29.09
Bioventus (BVS) United States $1.093B 17.10
Savara (SVRA) United States $1.081B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cybin (HELP) Canada $0.992B 0.00
Theravance Biopharma (TBPH) United States $0.885B 0.00
Avalo Therapeutics (AVTX) United States $0.862B 0.00
Ardelyx (ARDX) United States $0.847B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.821B 11.32
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Aclaris Therapeutics (ACRS) United States $0.773B 0.00
Achieve Life Sciences (ACHV) Canada $0.753B 0.00
4D Molecular Therapeutics (FDMT) United States $0.753B 0.00
Silence Therapeutics (SLN) United Kingdom $0.750B 0.00
Apnimed (APMD) $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.711B 3.13
Zevra Therapeutics (ZVRA) United States $0.692B 7.37
Ironwood Pharmaceuticals (IRWD) United States $0.671B 5.21
OmniAb (OABI) United States $0.630B 0.00
Altimmune (ALT) United States $0.628B 0.00
Aquestive Therapeutics (AQST) United States $0.604B 0.00
Evotec AG (EVO) Germany $0.580B 0.00
ProKidney (PROK) United States $0.526B 0.00
Indaptus Therapeutics (INDP) United States $0.485B 0.00
Relmada Therapeutics (RLMD) United States $0.474B 0.00
ARS Pharmaceuticals (SPRY) United States $0.423B 0.00
Larimar Therapeutics (LRMR) United States $0.406B 0.00
Prelude Therapeutics (PRLD) United States $0.361B 0.00
Century Therapeutics (IPSC) United States $0.359B 0.00
Lexeo Therapeutics (LXEO) United States $0.339B 0.00
Inhibikase Therapeutics (IKT) United States $0.322B 0.00
Avita Medical (RCEL) United States $0.314B 0.00
Pyxis Oncology (PYXS) United States $0.278B 0.00
USANA Health Sciences (USNA) United States $0.275B 15.05
Elite Pharmaceuticals (ELTP) United States $0.268B 12.44
Lyell Immunopharma (LYEL) United States $0.267B 0.00
Akebia Therapeutics (AKBA) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
Nature's Sunshine Products (NATR) United States $0.230B 11.17
AleAnna (ANNA) United States $0.226B 17.84
Protara Therapeutics (TARA) United States $0.222B 0.00
Cardiol Therapeutics (CRDL) Canada $0.215B 0.00
Siga Technologies (SIGA) United States $0.214B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
Korro Bio (KRRO) United States $0.207B 0.00
Surrozen (SRZN) United States $0.206B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.199B 0.00
Organogenesis (ORGO) United States $0.188B 0.00
Minerva Neurosciences (NERV) United States $0.183B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Atrium Therapeutics (RNA) United States $0.173B 0.00
NRx Pharmaceuticals (NRXP) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Unicycive Therapeutics (UNCY) United States $0.131B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
VAXART, INC (VXRT) United States $0.117B 3.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Rafael Holdings (RFL) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.111B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 0.00
PolyPid (PYPD) Israel $0.098B 0.00
HST Global (HSTC) United States $0.092B 0.00
ElectroCore (ECOR) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Nutriband (NTRB) United States $0.083B 0.00
Aldeyra Therapeutics (ALDX) United States $0.083B 0.00
Telomir Pharmaceuticals (TELO) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Acrivon Therapeutics (ACRV) United States $0.078B 0.00
Gain Therapeutics (GANX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Talphera (TLPH) United States $0.062B 0.00
Nuo Therapeutics (AURX) $0.061B 0.00
Heron Therapeutics (HRTX) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.053B 0.00
Veraxa Biotech AG (VRXA) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
Incannex Healthcare (IXHL) Australia $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Context Therapeutics (CNTX) United States $0.033B 0.00
Optimi Health (OPTH) Canada $0.029B 0.00
Cosmos Health (COSM) United States $0.028B 0.00
TransCode Therapeutics (RNAZ) United States $0.027B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Enlivex (ENLV) Israel $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Vyome Holdings (HIND) United States $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Nuvilex (PMCB) United States $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00